J Ivanidze1, R A Charalel2, I Shuryak3, D Brenner3, A Pandya4, O N Kallas2, K Kesavabhotla2, A Z Segal5, M S Simon6,7, P C Sanelli2,7. 1. From the Departments of Radiology (J.I., R.A.C., O.N.K., K.K., P.C.S.) jai9018@nyp.org. 2. From the Departments of Radiology (J.I., R.A.C., O.N.K., K.K., P.C.S.). 3. Department of Radiology (I.S., D.B.), NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, New York. 4. Department of Health Policy and Management (A.P.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 5. Neurology (A.Z.S.). 6. Internal Medicine and Public Health (M.S.S.), Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, New York. 7. Department of Radiology (M.S.S., P.C.S.), Northwell Health, Manhasset, New York.
Abstract
BACKGROUND AND PURPOSE: CT angiography and perfusion imaging is an important prognostic tool in the management of patients with aneurysmal subarachnoid hemorrhage. The purpose of this study was to perform a cost-effectiveness analysis of advanced imaging in patients with SAH, incorporating the risks of radiation exposure from CT angiography and CT perfusion imaging. MATERIALS AND METHODS: The risks of radiation-induced brain cancer and cataracts were incorporated into our established decision model comparing the cost-effectiveness of CT angiography and CT perfusion imaging and transcranial Doppler sonography in SAH. Cancer risk was calculated by using National Cancer Institute methodology. The remaining input probabilities were based on literature data and a cohort at our institution. Outcomes were expected quality-adjusted life years gained, costs, and incremental cost-effectiveness ratios. One-way, 2-way, and probabilistic sensitivity analyses were performed. RESULTS: CT angiography and CT perfusion imaging were the dominant strategies, resulting in both better health outcomes and lower costs, even when incorporating brain cancer and cataract risks. Our results remained robust in 2-way sensitivity analyses varying the prolonged latency period up to 30 years, with either brain cancer risk up to 50 times higher than the upper 95% CI limit or the probability of cataracts from 0 to 1. Results were consistent for scenarios that considered either symptomatic or asymptomatic patients with SAH. Probabilistic sensitivity analysis confirmed our findings over a broad range of selected input parameters. CONCLUSIONS: While risks of radiation exposure represent an important consideration, CT angiography and CT perfusion imaging remained the preferred imaging compared with transcranial Doppler sonography in both asymptomatic and symptomatic patients with SAH, with improved health outcomes and lower health care costs, even when modeling a significantly higher risk and shorter latency period for both cataract and brain cancer than that currently known.
BACKGROUND AND PURPOSE: CT angiography and perfusion imaging is an important prognostic tool in the management of patients with aneurysmal subarachnoid hemorrhage. The purpose of this study was to perform a cost-effectiveness analysis of advanced imaging in patients with SAH, incorporating the risks of radiation exposure from CT angiography and CT perfusion imaging. MATERIALS AND METHODS: The risks of radiation-induced brain cancer and cataracts were incorporated into our established decision model comparing the cost-effectiveness of CT angiography and CT perfusion imaging and transcranial Doppler sonography in SAH. Cancer risk was calculated by using National Cancer Institute methodology. The remaining input probabilities were based on literature data and a cohort at our institution. Outcomes were expected quality-adjusted life years gained, costs, and incremental cost-effectiveness ratios. One-way, 2-way, and probabilistic sensitivity analyses were performed. RESULTS: CT angiography and CT perfusion imaging were the dominant strategies, resulting in both better health outcomes and lower costs, even when incorporating brain cancer and cataract risks. Our results remained robust in 2-way sensitivity analyses varying the prolonged latency period up to 30 years, with either brain cancer risk up to 50 times higher than the upper 95% CI limit or the probability of cataracts from 0 to 1. Results were consistent for scenarios that considered either symptomatic or asymptomatic patients with SAH. Probabilistic sensitivity analysis confirmed our findings over a broad range of selected input parameters. CONCLUSIONS: While risks of radiation exposure represent an important consideration, CT angiography and CT perfusion imaging remained the preferred imaging compared with transcranial Doppler sonography in both asymptomatic and symptomatic patients with SAH, with improved health outcomes and lower health care costs, even when modeling a significantly higher risk and shorter latency period for both cataract and brain cancer than that currently known.
Authors: Helen McCarter; William Furlong; Anthony C Whitton; David Feeny; Sonja DePauw; Andrew R Willan; Ronald D Barr Journal: J Clin Oncol Date: 2006-08-01 Impact factor: 44.544
Authors: S Diekmann; E Siebert; R Juran; M Roll; W Deeg; H-C Bauknecht; F Diekmann; R Klingebiel; G Bohner Journal: AJNR Am J Neuroradiol Date: 2010-01-28 Impact factor: 3.825
Authors: Philip M Meyers; H Christian Schumacher; Randall T Higashida; Colin P Derdeyn; Gary M Nesbit; David Sacks; Lawrence R Wechsler; Joshua B Bederson; Sean D Lavine; Peter Rasmussen Journal: J Neurointerv Surg Date: 2010-09-21 Impact factor: 5.836
Authors: J Ivanidze; K Kesavabhotla; O N Kallas; D Mir; H Baradaran; A Gupta; A Z Segal; J Claassen; P C Sanelli Journal: AJNR Am J Neuroradiol Date: 2015-01-08 Impact factor: 3.825
Authors: Mellanie V Springer; J Michael Schmidt; Katja E Wartenberg; Jennifer A Frontera; Neeraj Badjatia; Stephan A Mayer Journal: Neurosurgery Date: 2009-12 Impact factor: 4.654
Authors: Jan Willem Dankbaar; Nicolien K de Rooij; Birgitta K Velthuis; Catharina J M Frijns; Gabriel J E Rinkel; Irene C van der Schaaf Journal: Stroke Date: 2009-09-17 Impact factor: 7.914
Authors: Juan Martino; Elsa Gomez; José L Bilbao; Juan C Dueñas; Alfonso Vázquez-Barquero Journal: Acta Neurochir (Wien) Date: 2012-11-07 Impact factor: 2.216
Authors: P C Sanelli; N Anumula; C E Johnson; J P Comunale; A J Tsiouris; H Riina; A Z Segal; P E Stieg; R D Zimmerman; A I Mushlin Journal: AJNR Am J Neuroradiol Date: 2012-08-02 Impact factor: 3.825
Authors: Amr Abdulazim; Carla Küppers; Katharina A M Hackenberg; Eva Neumaier-Probst; Mohamad Mansour Alzghloul; Jörg Krebs; Manfred Thiel; Hester Lingsma; Gabriel J E Rinkel; Christoph Groden; Nima Etminan Journal: Acta Neurochir (Wien) Date: 2022-08-25 Impact factor: 2.816
Authors: Artem T Boltyenkov; Gabriela Martinez; Ankur Pandya; Jeffrey M Katz; Jason J Wang; Jason J Naidich; Elizabeth Rula; Pina C Sanelli Journal: Front Neurol Date: 2021-11-26 Impact factor: 4.003